Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 138 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 2214. Clear
Clear
Q1
ELEVANCE HEALTH, INC. for ELEVANCE HEALTH, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Health Issues, Insurance, Medicare/Medicaid, Pharmacy
View → Q1
THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES) for THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Medicare/Medicaid, Health Issues, Defense, Pharmacy
View → Q1
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View → Q1
EMERGENT STRATEGIES for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy
View → Q1
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Medicare/Medicaid, Health Issues, Pharmacy
View → Q1
PRIME THERAPEUTICS for PRIME THERAPEUTICS
1st Quarter (Jan 1 - Mar 31) 2025 · Minnesota · House · Senate
Health Issues, Medicare/Medicaid, Trade (domestic/foreign)
View → Q1
JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC
1st Quarter (Jan 1 - Mar 31) 2025 · New Jersey · House · Senate
Pharmacy, Science/Technology, Taxation/Internal Revenue Code, Veterans
View → Q1
NOVARTIS for NOVARTIS
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View → Q1
HOOPER, LUNDY & BOOKMAN, P.C. for GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS
1st Quarter (Jan 1 - Mar 31) 2025 · Florida · House · Senate · $10,000.00 income
Medicare/Medicaid, Health Issues
View → 1A
RYAN COSTELLO STRATEGIES for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · $50,000.00 income
Health Issues
View → Q1
RYAN COSTELLO STRATEGIES for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · $50,000.00 income
Health Issues
View → Q1
ADVANCED POLICY CONSULTING, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $40,000.00 income
Health Issues
View → Q1
STUMPTOWN STRATEGIES for PRIME THERAPEUTICS
1st Quarter (Jan 1 - Mar 31) 2025 · Minnesota · House · Senate · $20,000.00 income
Health Issues, Pharmacy
View →
Previous Page 6 of 6

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem